Indo Us Biotech Limited — Others, 22-11-2024: Corrigendum

Indo Us Bio-Tech Limited has announced a board meeting regarding an increase in its authorized share capital from ₹21 crore to ₹32 crore, along with necessary amendments to the Memorandum of Association. This change aims to position the company for future growth opportunities. The board seeks shareholder approval for the resolutions associated with this alteration. Investors may view this move positively as it indicates strategic plans to raise capital and expand operations, potentially enhancing shareholder value in the long term.